Cargando…
Role of radiomics in predicting immunotherapy response
Immunotherapies have revolutionised cancer management. Despite their success, durable responses are limited to a subset of patients. Prediction of immunotherapy response in patients has proven to be difficult due to a lack of robust biomarkers. Routinely collected imaging may offer an additional inf...
Autor principal: | Kothari, Gargi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323544/ https://www.ncbi.nlm.nih.gov/pubmed/35581928 http://dx.doi.org/10.1111/1754-9485.13426 |
Ejemplares similares
-
Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence
por: Kim, Nari, et al.
Publicado: (2022) -
Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy
por: Czajkowski, Daniel, et al.
Publicado: (2022) -
Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma
por: Kawazoe, Yusuke, et al.
Publicado: (2023) -
Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018) -
Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up
por: Gutkin, Paulina M, et al.
Publicado: (2018)